MICHAEL WHITE
Pharmacy at Mcknight Rd, Pittsburgh, PA

6410926, Jun 25, 2002

Oct 1, 1999

09/410776

Calum H. Munro - Wexford PA
Michael L. White - Pittsburgh PA
Michael J. Pawlik - Shaler Township PA
Ralph C. Gray - Butler PA
Gregory J. McCollum - Hampton Township PA

PPG Industries Ohio, Inc. - Cleveland OH

G01N 2164

2504591, 250302

A method for determining the thickness of a dryable or curable film-forming coating by incorporating a fluorescent component into the coating. The fluorescent component is either a resin solid of the coating, a fluorescent dye or a fluorescent dye attached to a resin solid of the coating. The coating is exposed to ultraviolet or visible light which causes the fluorescent component to fluoresce. The intensity of the fluorescence of the coating is measured and the thickness or weight of the coating is determined from a known mathematical relationship between the fluorescence intensity of the coating when exposed to the light and the thickness or weight of the coating. Additionally, a curable or dryable film-forming coating composition including a curable or dryable organic resin reacted with a fluorescent tag is provided.

5529912, Jun 25, 1996

May 30, 1995

8/453477

Susan A. Henry - Pittsburgh PA
Michael J. White - Pittsburgh PA

Carnegie Mellon University - Pittsburgh PA

C12P 702, C12P 764, C12N 912, C12N 119

435155

A yeast cell, preferably Saccharomyces cerevisiae, which contains a functional stable recombinant DNA sequence that does not allow for the encoding of a negative regulator of phospholipid biosynthesis therein and which has multiple copies of an INO1 gene. In a preferred embodiment, the recombinant DNA sequence is an OPI1 gene deletion which results in the deregulation of inositol or inositol-containing metabolites such as inositol-1-phosphate synthase. Moreover, there is a method for obtaining inositol, inositol-containing metabolites or phospholipids such as myo-inositol or inositol-1-phosphate. The method comprises the steps of genetically engineering a stable yeast cell, preferably Saccharomyces cerevisiae, to continually produce inositol, inositol-containing metabolites or phospholipids. Additionally, there is the step of then generating the inositol, inositol-containing metabolites or phospholipids. In a preferred embodiment, the genetically engineering step includes the step of altering the negative regulatory step involved in phospholipid biosynthesis to overproduce inositol, inositol-containing metabolites or phospholipids such as myo-inositol.

7497935, Mar 3, 2009

Aug 27, 2004

10/928770

Gregory J. McCollum - Gibsonia PA, US
Michael L. White - Pittsburgh PA, US

PPG Industries Ohio, Inc. - Cleveland OH

C25D 13/06

204489, 204493, 204505, 523415

The invention provides a curable electrodepositable coating composition that has improved durability in the presence of metal ions. The coating composition includes one or more ungelled, active hydrogen-containing ionic salt group-containing resins which are electrodepositable on an electrode, one or more curing agents, and one or more metal deactivators.

5972189, Oct 26, 1999

May 29, 1998

9/087211

Neil D. McMurdie - Pittsburgh PA
Robert R. Zwack - Allison Park PA
Matthew S. Scott - Pittsburgh PA
Michael L. White - Pittsburgh PA

PPG Industries Ohio, Inc. - Cleveland OH

C25D 1304

204501

An electrodepositable composition is provided comprising (a) an active hydrogen-containing, cationic salt group-containing resin electrodepositable on a cathode; (b) a capped polyisocyanate curing agent; and (c) bismuth diorganodithiocarbamate. Such compositions may be prepared without the use of conventional lead or tin catalysts and exhibit excellent properties as cured coatings. Also provided is a method of electrocoating an electroconductive substrate using the composition of the present invention.